As of December 2024, Summit Therapeutics has a market cap of $13.09B. This makes Summit Therapeutics the world's 622th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.17B | 73.18% |
2023 | $1.83B | -38.59% |
2022 | $2.98B | 57.99% |
2021 | $1.89B | -42.77% |
2020 | $3.29B | 193.75% |
2019 | $1.12B | 39.13% |
2018 | $805.97M | -89.62% |
2017 | $7.77B | 29.44% |
2016 | $6.00B | -25.57% |
2015 | $8.06B | - |